Early research (Phase 1)Study completedNCT06675175
What this trial is testing
A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.
Who this might be right for
Chronic Kidney DiseaseAtherosclerotic Cardiovascular Disease
AstraZeneca 29